Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus

por Sun, Kefeng, Hayes, Siobhan, Farrell, Colm, Song, Ivy H.
Publicado 2023

Population Pharmacokinetic Analysis of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

por Mehta, Rashmi, Farrell, Colm, Hayes, Siobhán, Birk, Ruby, Okour, Malek, Lipson, David A.
Publicado 2019

Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients

por Zhang, Jianping, Hayes, Siobhán, Sadler, Brian M, Minto, Ilisse, Brandt, Julie, Piscitelli, Steve, Min, Sherene, Song, Ivy H
Publicado 2015

Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents

por Chandasana, Hardik, Thapar, Mita, Hayes, Siobhan, Baker, Mark, Gibb, Diana M., Turkova, Anna, Ford, Deborah, Ruel, Theodore, Wiznia, Andrew, Fairlie, Lee, Bwakura-Dangarembizi, Mutsa, Mujuru, Hilda, Alvero, Carmelita, Farhad, Mona, Hazra, Rohan, Townley, Ellen, Buchanan, Ann, Bollen, Pauline, Waalewijn, Hylke, Colbers, Angela, Burger, David, Acosta, Edward P., Singh, Rajendra
Publicado 2023